Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Prostate cancer: Could a single blood test replace TRUS for predicting prostate cancer risk?

Clyne M.

Nat Rev Urol. 2013 Apr;10(4):183. doi: 10.1038/nrurol.2013.50. Epub 2013 Mar 19. No abstract available.

PMID:
23507932
3.

Contrast-enhanced transrectal ultrasound (CE-TRUS) with cadence-contrast pulse sequence (CPS) technology for the identification of prostate cancer.

Seitz M, Gratzke C, Schlenker B, Buchner A, Karl A, Roosen A, Singer BB, Bastian PJ, Ergün S, Stief CG, Reich O, Tilki D.

Urol Oncol. 2011 May-Jun;29(3):295-301. doi: 10.1016/j.urolonc.2009.03.032. Epub 2009 Jun 12.

PMID:
19523857
4.

Transrectal ultrasound in the diagnosis of prostate cancer: state of the art and perspectives.

Sedelaar JP, Vijverberg PL, De Reijke TM, de la Rosette JJ, Kil PJ, Braeckman JG, Hendrikx AJ.

Eur Urol. 2001 Sep;40(3):275-84. Review.

PMID:
11684843
5.
8.

A more advanced clinical stage is positively correlated with an increased prostate cancer detection rate.

Roobol MJ, Kranse R, van der Cruijsen IW, Schröder FH.

Urology. 2002 Jan;59(1):91-6.

PMID:
11796288
9.

Prediction of prostate cancer risk: the role of prostate volume and digital rectal examination in the ERSPC risk calculators.

Roobol MJ, van Vugt HA, Loeb S, Zhu X, Bul M, Bangma CH, van Leenders AG, Steyerberg EW, Schröder FH.

Eur Urol. 2012 Mar;61(3):577-83. doi: 10.1016/j.eururo.2011.11.012. Epub 2011 Nov 15.

PMID:
22104592
12.

The role of colour Doppler ultrasonography in detecting prostate cancer.

Shigeno K, Igawa M, Shiina H, Wada H, Yoneda T.

BJU Int. 2000 Aug;86(3):229-33.

13.

Correlation between prostate size estimated by digital rectal examination and measured by transrectal ultrasound.

Roehrborn CG, Girman CJ, Rhodes T, Hanson KA, Collins GN, Sech SM, Jacobsen SJ, Garraway WM, Lieber MM.

Urology. 1997 Apr;49(4):548-57.

PMID:
9111624
14.

Computerized transrectal ultrasound (C-TRUS) of the prostate: detection of cancer in patients with multiple negative systematic random biopsies.

Loch T.

World J Urol. 2007 Aug;25(4):375-80. Epub 2007 Aug 11. Erratum in: World J Urol. 2013 Aug;31(4):1019.

PMID:
17694312
15.

Experience with an assay for prostate-specific antigen and transrectal ultrasonography in the diagnosis of prostate cancer.

Heman-Ackah CA, Festenstein JB, Hibbert P, Harvey DJ, Bunce CJ, Gelister JS.

Br J Urol. 1997 Mar;79(3):439-44.

PMID:
9117228
16.

Transrectal ultrasonography-guided biopsy does not reliably identify dominant cancer location in men with low-risk prostate cancer.

Washington SL, Bonham M, Whitson JM, Cowan JE, Carroll PR.

BJU Int. 2012 Jul;110(1):50-5. doi: 10.1111/j.1464-410X.2011.10704.x. Epub 2011 Nov 11.

17.

Computerized transrectal ultrasound of the prostate in a multicenter setup (C-TRUS-MS): detection of cancer after multiple negative systematic random and in primary biopsies.

Grabski B, Baeurle L, Loch A, Wefer B, Paul U, Loch T.

World J Urol. 2011 Oct;29(5):573-9. doi: 10.1007/s00345-011-0713-0. Epub 2011 Jun 21.

PMID:
21691722
18.
19.

A comparison of CT scan to transrectal ultrasound-measured prostate volume in untreated prostate cancer.

Hoffelt SC, Marshall LM, Garzotto M, Hung A, Holland J, Beer TM.

Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):29-32.

PMID:
12909212
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk